BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/19/2024 12:00:22 PM | Browse: 61 | Download: 187
 |
Received |
|
2024-06-15 04:58 |
|
Peer-Review Started |
|
2024-06-15 04:58 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-08-11 12:03 |
|
Revised |
|
2024-08-16 15:24 |
|
Second Decision |
|
2024-09-10 02:47 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-09-10 08:00 |
|
Articles in Press |
|
2024-09-10 08:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-09-13 00:14 |
|
Publish the Manuscript Online |
|
2024-09-19 12:00 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Dermatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Medical dilemma: Programmed death 1 blockade (sintilimab) therapy in patients suffering from tumours combined with psoriasis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Di Jin, Yu-Wei Wang, Zhi-Min Lin, Ming Li and Chen Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Weifang Health Commission's Scientific Research Program |
No. WFWSJK-2023-222; and No. WFWSJK-2023-240 |
| the Weifang Young Medical Talent Support Project |
|
|
| Corresponding Author |
Ming Li, Department of Rheumatology, Weifang people’s Hospital, No. 151 Guangwen Street, Kuiwen District, Weifang 261000, Shandong Province, China. lalwlm@aliyun.com |
| Key Words |
Immune checkpoint inhibitors; Tumor immunotherapy; Immune-related adverse events; Cytokine release syndrome; Psoriasis |
| Core Tip |
The major strategies for dealing with immune-related adverse events should include scientific awareness, early diagnosis and graded management. The important direction of tumour immunotherapy research is how to reduce the adverse effects of immunotherapy and can improve the quality of patient survival. The correlation between programmed cell death protein-1 inhibitors and chronic psoriasis is gradually receiving more and more attention, and how to screen high-risk populations in the future, as well as to give the necessary and effective preventive therapeutic measures still need to be further explored. |
| Publish Date |
2024-09-19 12:00 |
| Citation |
<p>Jin D, Wang YW, Lin ZM, Li M, Li C. Medical dilemma: Programmed death 1 blockade (sintilimab) therapy in patients suffering from tumours combined with psoriasis. <i>World J Cardiol</i> 2024; 16(9): 546-549</p> |
| URL |
https://www.wjgnet.com/1949-8462/full/v16/i9/546.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v16.i9.546 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
